Synergistic and additive anti-tumor effects of MIV-818 in combination with sorafenib in nonclinical hepatocellular carcinoma models

被引：0
|
作者：
Rizoska, Biljana [1 ]
Bylund, Johan [1 ]
Briem, Sveinn [1 ]
Kyle, Alastair [2 ]
Minchinton, Andrew [2 ]
Oberg, Fredrik [1 ]
Gohlin, Karin [1 ]
Albertella, Mark [1 ]
机构：
[1] Medivir AB, Huddinge, Sweden
[2] BC Canc, Vancouver, BC, Canada
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-2930
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2930
引用
收藏
页数：2
相关论文
共 50 条
  • [1] FOSTROX (MIV-818) IN COMBINATION WITH ANTI-PD-1 SHOWS INCREASED EFFICACY IN NONCLINICAL TUMOR MODELS IN VIVO
    Oberg, Fredrik
    Bhoi, Sujata
    Jensen, Malene
    Morris, Tom
    Tunblad, Karin
    Wallberg, Hans
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A475 - A475
  • [2] SYNERGISTIC ANTI-TUMOR EFFECT OF SORAFENIB IN COMBINATION WITH AKT INHIBITORS IN HEPATOCELLULAR CARCINOMA
    Feng, W. -C.
    Hsu, C. -H.
    Lin, S. -D.
    Lin, H. -H.
    Hsu, D. -W.
    Huang, C. -C.
    Chow, L. -P.
    Cheng, A. -L.
    ANNALS OF ONCOLOGY, 2012, 23 : 16 - 16
  • [3] A triple combination of fostrox (MIV-818) with immune checkpoint and kinase inhibition shows increased anti-tumor efficacy in vivo
    Oberg, Fredrik G.
    Bhoi, Sujata
    Jensen, Malene
    Tunblad, Karin
    Wallberg, Hans
    CANCER RESEARCH, 2023, 83 (07)
  • [4] Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
    Cheng, Yang
    Luo, RongCheng
    Zheng, Hang
    Wang, Biao
    Liu, YaHui
    Liu, DingLi
    Chen, JinZhang
    Xu, WanFu
    Li, AiMin
    Zhu, Yun
    ONCOTARGET, 2017, 8 (14) : 23265 - 23276
  • [5] Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
    Ou, Da-Liang
    Chang, Chun-Jung
    Jeng, Yung-Ming
    Lin, Yi-Jang
    Lin, Zhong-Zhe
    Gandhi, Anita K.
    Liao, Sheng-Chieh
    Huang, Zi-Ming
    Hsu, Chiun
    Cheng, Ann-Lii
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (12) : 2021 - 2031
  • [6] Synergistic and additive effects of ATRA in combination with different anti-tumor compounds
    Schultze, Eduarda
    Collares, Tiago
    Lucas, Caroline G.
    Seixas, Fabiana K.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2018, 285 : 69 - 75
  • [7] Anti-tumor activity of sorafenib in a model of a pediatric hepatocellular carcinoma
    Nagel, Carmen
    Armeanu-Ebinger, Sorin
    Dewerth, Alexander
    Warmann, Steven W.
    Fuchs, Joerg
    EXPERIMENTAL CELL RESEARCH, 2015, 331 (01) : 97 - 104
  • [8] Combined anti-tumor effects of IFN-α and sorafenib on hepatocellular carcinoma in vitro and in vivo
    Wang, Lijing
    Jia, Dongwei
    Duan, Fangfang
    Sun, Zhichao
    Liu, Xiaojuan
    Zhou, Lei
    Sun, Linlin
    Ren, Shifang
    Ruan, Yuanyuan
    Gu, Jianxin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 422 (04) : 687 - 692
  • [9] Antrodia cinnamomea boosts the anti-tumor activity of sorafenib in xenograft models of human hepatocellular carcinoma
    Wei-De Wu
    Pin-Shern Chen
    Hany A. Omar
    El-Shaimaa A. Arafa
    Hung-Wei Pan
    Jingyueh Jeng
    Jui-Hsiang Hung
    Scientific Reports, 8
  • [10] Antrodia cinnamomea boosts the anti-tumor activity of sorafenib in xenograft models of human hepatocellular carcinoma
    Wu, Wei-De
    Chen, Pin-Shern
    Omar, Hany A.
    Arafa, El-Shaimaa A.
    Pan, Hung-Wei
    Jeng, Jingyueh
    Hung, Jui-Hsiang
    SCIENTIFIC REPORTS, 2018, 8
12345